产品分类

 抗核抗体(小鼠肾、胃、肝)荧光试剂盒

          微信扫一扫

杨永汉

QQ：3012818662 洪小姐

广州健仑生物科技有限公司为美国INova核心代理。

【INova简介】

INova是一个非盈利性的医疗系统，在北弗吉尼亚地区每年服务人数超过二百万人，从1956年的一家医院到得到国家认可，目前医院已经形成医院网络综合服务、门诊服务、初级及特殊医疗护理、健康和保健服务体系。
INOVA 诊断公司，创办于 1987 年，总部位于美国圣地亚哥市， 2008 年加入西班牙 Werfen 集团，是一家 20 年来一直致力于自身免疫疾病诊断领域的专业生物技术公司。公司现构建了一支由资深生物技术专家、生产质量控制专家及市场营销专家等共 240 名员工构成的精英团队，专注研发及生产一批批技术新颖、性能独特、质量稳定、使用更广泛的自身免疫抗体检测试剂和设备，并全力服务于客户。
INOVA 公司目前已经为全球 90 多个国家的用户包括许多世界*医疗机构提供一系列涵盖多种自身免疫疾病的诊断试剂和仪器。公司一直致力于以非凡的技术能力、产品支持和无可挑剔的服务，用创新的试剂和系统满足今天日益增长的对自身免疫疾病检测的质量和效率的要求。
广州健仑生物科技有限公司为美国INova核心代理。
INOVA 是全球自身免疫试剂研发的标杆企业，美国市场占有率60-70%，欧洲市场占有率30%。50多个项目首先取得美国FDA认证。特色项目有血栓症诊断系列 、 结缔组织病 、 类风湿性关节炎 、 肝肾疾病诊断系列 、脉管炎诊断系列 、 内分泌诊断系列 、 IFA系列产品、阳性质控品、CCP3，以及肝肾系列，抗心磷脂系列，质量均优于目前市面所有品牌。

本公司部分inova自身免疫系列产品！

[introduction of INova]

 INova is a nonprofit medical system, serving more than two million people a year in the North Virginia region, from a hospital in 1956 to a national recognition. The hospital has formed a hospital network integrated service, outpatient service, primary and special medical care, health and health care services.
INOVA diagnostics, founded in 1987, was based in Santiago, USA, and joined the Spanish Werfen group in 2008. It is a professional Biotech Corp that has been working on the diagnosis of autoimmune diseases for 20 years. The company has established an elite team of 240 employees, including senior biotech experts, production quality control experts and marketing experts. It focuses on the development and production of a batch of new, unique, stable and widely used autoimmune anti physical testing agents and equipment. Household.
INOVA has now provided a series of diagnostic reagents and instruments covering a wide range of autoimmune diseases for users in more than 90 countries, including many of the world's top medical institutions. The company has been working to meet today's growing requirements for the quality and efficiency of the detection of autoimmune diseases with innovative technical capabilities, product support and impeccable services, with innovative reagents and systems.
Guangzhou Jian Lun Biotechnology Co., Ltd. is the core agent of INova in the US.
INOVA is a benchmark enterprise for the development of global autoimmune reagents. The US market share is 60-70%, and the European market share is 30%. The more than 50 projects first obtained the FDA certification of the United States. Characteristic items include thrombosis diagnosis series, connective tissue disease, rheumatoid arthritis, liver and kidney disease diagnosis series.
The diagnosis series of vasculitis, the endocrine diagnosis series, the IFA series products, the positive quality control products, the CCP3, the liver and kidney series, the anticardiolipin series are superior to all the current market brands.